tiprankstipranks
Trending News
More News >

Fusen Pharmaceutical Postpones Board Meeting to Finalize Annual Results

Story Highlights
Fusen Pharmaceutical Postpones Board Meeting to Finalize Annual Results

Don’t Miss TipRanks’ Half-Year Sale

Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ) has shared an announcement.

Fusen Pharmaceutical Company Limited, a company incorporated in the Cayman Islands, has announced a change in the date of its board meeting. Originally scheduled for March 28, 2025, the meeting has been postponed to March 31, 2025, to allow additional time for finalizing the company’s annual results for the year ended December 31, 2024. This delay may impact the timing of the approval and publication of the annual results and the consideration of a final dividend.

More about Fusen Pharmaceutical Co., Ltd.

YTD Price Performance: -65.62%

Average Trading Volume: 454,837

Technical Sentiment Signal: Buy

Current Market Cap: HK$202.2M

For detailed information about 1652 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1